GNA Biosolutions raised $13.5 million to support its point-of-care molecular diagnostics platform designed to quickly examine samples taken from whole blood, sputum and nasal swabs. The Munich-based ...
BERLIN (Reuters) - Biotech firm GNA Biosolutions said on Tuesday it has received emergency use approval from German's health authority for its quick COVID-19 test that it says is as reliable as widely ...
GNA Biosolutions was named the winner of the American Association of Clinical Chemistry’s (AACC) Disruptive Technology Award competition, held on Monday evening at the 70th AACC Annual Scientific ...
INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever ...
GNA Biosolutions GmbH, a German molecular diagnostics company, has secured $13.5 million in Series C financing. The investors included GreyBird Ventures, Occident, Wachtumsfonds Bayern, SHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results